FDA Eliminates Regulatory Oversight for AI Health Devices and Wearables in Major Deregulation Move
FDA eliminates regulatory oversight for AI health devices and wearables in sweeping deregulation move, allowing clinical decision support software to enter markets without review as Commissioner Makary prioritizes 'Silicon Valley speed' over traditional safety protocols.